0001615219-22-000004.txt : 20220121 0001615219-22-000004.hdr.sgml : 20220121 20220121160337 ACCESSION NUMBER: 0001615219-22-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220120 FILED AS OF DATE: 20220121 DATE AS OF CHANGE: 20220121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosenblum Mark J CENTRAL INDEX KEY: 0001329154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 22545940 MAIL ADDRESS: STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218 CITY: DALLAS STATE: TX ZIP: 75244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_164279899941926.xml FORM 4 X0306 4 2022-01-20 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001329154 Rosenblum Mark J C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOMBE BLVD., SUITE X HOUSTON TX 77021 0 1 0 0 Exec VP Finance, CFO Stock Option (right to buy) 0.48 2022-01-20 4 A 0 200000 0 A 2032-01-19 Common Stock 200000.0 200000 D 25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter. /s/ Mark J. Rosenblum 2022-01-21